MDM2

There are 121 papers on MDM2 in aging research: 1 trial and 9 observational studies in people, 61 in animals, 35 in cells, 6 reviews. The newest story, Nov 17, 2026: “Stress-response protein supports healthy aging in mouse liver”.

Gene

121 papers study it25 findings

HGNCNCBI GeneTaxon

4 new papers in 30 daysSee all 121 papers on MDM2

At a glance

The findings reach people, from one lab or study; independent labs found the same change in cells. 14 independent labs in 6 countries; 1 trial.

“Altogether, our findings indicate that mutant MDM2 is a likely driver of the observed segmental form of progeria.”
Dysfunction of the MDM2/p53 axis is linked to premature agingThe Journal of clinical investigation2017doi:10.1172/jci92171

2 of its findings point the other way.

Cells: replicated by independent labs. Mice and humans: a single group. Worms or flies: nothing yet.
  • 14 independent labs in 6 countries
  • 2 findings against
  • 1 trial
  • Funders: National Cancer Institute and others
  • 3 of 25 findings with company ties
  • 1 of 1 trial sponsored by developers of drugs aimed at it
  • Human trial1
  • Humans9
  • Animals60
  • Model organisms1
  • Cells35
  • In silico9

Interventions

1

Urolithin A

downin human cells1

1 study
  1. Urolithin A decreases MDM2 in p53-null PC3 cells.

    “UA downregulated MDM2 and XIAP protein expression in PC3 cells”

    Cellsin p53-null PC3 cells

    Urolithin A induces prostate cancer cell death in p53-dependent and in p53-independent manner

    European journal of nutrition

More on Urolithin A

Effects

14

Cellular senescence

upin human cells2upin mice1downin mice1downin rat cells1

4 studies
  1. MDM2 increases cellular senescence in human cells (H2O2-stimulated cells; shown by MDM2 knockout).

    “Knockout of renal tubular MDM2 alleviated renal senescence in aged mice and in H2O2-stimulated HK2 cells.”

    CellsH2O2-stimulated cells; shown by MDM2 knockoutHK2

    MDM2 accelerated renal senescence via ubiquitination and degradation of HDAC1

    Acta pharmacologica Sinica

  2. MDM2 increases cellular senescence in mice (shown by renal tubular MDM2 knockout).

    “Knockout of renal tubular MDM2 alleviated renal senescence in aged mice and in H2O2-stimulated HK2 cells.”

    Animalsshown by renal tubular MDM2 knockoutrenal tubule

    MDM2 accelerated renal senescence via ubiquitination and degradation of HDAC1

    Acta pharmacologica Sinica

  3. MDM2 induces cellular senescence in human cells (overexpression in HDF).

    “MDM2-C overexpression induced senescence of HDF”

    Cellsoverexpression in HDF

    SRSF7 downregulation induces cellular senescence through generation of MDM2 variants

    Aging

  4. MDM2 decreases cellular senescence in rat cells (decreased Mdm2 expression, reversed by Mdm2 overexpression).

    “decreased Mdm2 expression led to senescence-associated phenotypes along with increased p53 and p21 protein abundance, which could all be reversed by Mdm2 overexpression”

    Cellsdecreased Mdm2 expression, reversed by Mdm2 overexpression

    Tempo-spatial alternative polyadenylation analysis reveals that 3' UTR lengthening of Mdm2 regulates p53 expression and cellular senescence in aged rat testis

    Biochemical and biophysical research communications

  5. MDM2 decreases cellular senescence in mice (Mdm2 deletion).

    “These phenotypes arise due to an induction of p53-mediated senescence in epidermal stem cells”

    AnimalsMdm2 deletionskin

    Mdm2-p53 signaling regulates epidermal stem cell senescence and premature aging phenotypes in mouse skin

    Developmental biology

More on Cellular senescence

Tumor

downin mice1

1 study
  1. MDM2 protects against tumor in mice (p53-wildtype in-vivo setting).

    “Moreover, in a p53-wildtype in-vivo setting, this isoform confers a protective effect against age-induced neoplasia.”

    Animalsp53-wildtype in-vivo setting

    Conserved sequence elements in the final exon of MDM2-eight-exon skipping event reveal a 'cassette regulon' model of alternative splicing controlled by a distal regulatory element

    bioRxiv : the preprint server for biologyPreprint

More on Tumor

p53–p21 pathway

downin human cells1

1 study
  1. MDM2 decreases p53–p21 pathway in COL1A1-edited cells.

    “by down-regulating p53 and p21 levels through the increased expression of MDM2 in the edited cells”

    Cellsin COL1A1-edited cells

    Mutation of the Collagen Type 1α Gene in Human Fibrosarcoma Cells Using the CRISPR/Cas9 System

    Biochemistry

More on p53–p21 pathway

HDAC1 ubiquitination and degradation

upin human cells1

1 study
  1. MDM2 increases HDAC1 ubiquitination and degradation in human cells.

    “MDM2 promoted renal senescence by orchestrating the ubiquitination and subsequent degradation of HDAC1.”

    CellsHK2

    MDM2 accelerated renal senescence via ubiquitination and degradation of HDAC1

    Acta pharmacologica Sinica

FOXO3

downin mouse cells1

1 study
  1. MDM2 decreases FOXO3 in mouse cells (downstream of DBC1).

    “DBC1 transcriptionally regulated mouse double minute 2 (MDM2), which mediated ubiquitination and degradation of forkhead box O3 (FOXO3)”

    Cellsdownstream of DBC1

    DBC1 maintains skeletal muscle integrity by enhancing myogenesis and preventing myofibre wasting

    Journal of cachexia, sarcopenia and muscle

More on FOXO3

Senescent fibroblast survival

upin human cells1

1 study
  1. MDM2 increases senescent fibroblast survival in human cells (senescent cells).

    “MDM2 and RNASE4 transcription is also elevated in human senescent fibroblasts to restrain p53 and promote survival.”

    Cellssenescent cellsfibroblast

    Senescent cells limit p53 activity via multiple mechanisms to remain viable

    Nature communications

p53-mediated apoptosis

downin mouse cells1

1 study
  1. MDM2 inhibits p53-mediated apoptosis in mouse cells (senescent cells; shown through gene knockdown).

    “Of these, Mdm2, Rnase4, and Ang act by suppressing p53-mediated apoptosis through various mechanisms that are also engaged in response to DNA damage.”

    Cellssenescent cells; shown through gene knockdownembryonic fibroblast

    Senescent cells limit p53 activity via multiple mechanisms to remain viable

    Nature communications

Mortality

upin mice1

1 study
  1. MDM2 increases mortality in mice (curtailing Mdm2 C-terminal length by a single amino acid).

    “curtailing Mdm2 C-terminal length by even a single amino acid leads to p53-dependent embryonic lethality”

    Animalscurtailing Mdm2 C-terminal length by a single amino acid

    Alterations of the Mdm2 C-Terminus Differentially Impact Its Function In Vivo

    Cancer research

Lifespan

downin mice1

1 study
  1. MDM2 shortens lifespan in mice (Mdm2 C-terminal extension by five amino acids (QLTCL)).

    “Extension of the Mdm2 C-terminal length by five amino acids (QLTCL) yielded viable mice that are smaller in size, exhibit fertility problems, and have a shortened life span.”

    AnimalsMdm2 C-terminal extension by five amino acids (QLTCL)

    Alterations of the Mdm2 C-Terminus Differentially Impact Its Function In Vivo

    Cancer research

P53 protein abundance

downin rat cells1

1 study
  1. MDM2 decreases P53 protein abundance in rat cells (decreased Mdm2 expression, reversed by Mdm2 overexpression).

    “decreased Mdm2 expression led to senescence-associated phenotypes along with increased p53 and p21 protein abundance, which could all be reversed by Mdm2 overexpression”

    Cellsdecreased Mdm2 expression, reversed by Mdm2 overexpression

    Tempo-spatial alternative polyadenylation analysis reveals that 3' UTR lengthening of Mdm2 regulates p53 expression and cellular senescence in aged rat testis

    Biochemical and biophysical research communications

More on P53 protein abundance

All 14

Upstream

2

USP13

downin human cells1downin mice1

1 study
  1. USP13 decreases MDM2 in human cells.

    “Knockdown of USP13 increased MDM2 levels in lung cells, while overexpression of USP13 reduced it.”

    Cellslung cells

    USP13 regulates cell senescence through mediating MDM2 stability

    Life sciences

  2. USP13 decreases MDM2 in mice (shown by USP13 deficiency).

    “The increased protein levels of MDM2 were detected in lung tissues of USP13 deficient mice.”

    Animalsshown by USP13 deficiencylung

    USP13 regulates cell senescence through mediating MDM2 stability

    Life sciences

More on USP13

NUR77

downin mouse cells1

1 study
  1. NUR77 inhibits MDM2 in mouse cells (shown by overexpression).

    “through negative transcriptional regulation of the E3 ligase MDM2”

    Cellsshown by overexpression

    Oxidative stress impairs the Nur77-Sirt1 axis resulting in a decline in organism homeostasis during aging

    Aging cell

More on NUR77

Associations

3

Apoptosis

mixedin mouse cells1

1 study
  1. MDM2 is associated with apoptosis in mouse cells (constitutive expression of Mdm2-MS2 isoform in NIH3T3 cells).

    “Constitutive expression of the Mdm2-MS2 isoform (the mouse ortholog of the human MDM2-ALT1 splice variant), achieved by mutating the Srsf2 binding-site on exon 11, modulates proliferation and apoptosis dynamics in NIH3T3 cells.”

    Cellsconstitutive expression of Mdm2-MS2 isoform in NIH3T3 cells

    Conserved sequence elements in the final exon of MDM2-eight-exon skipping event reveal a 'cassette regulon' model of alternative splicing controlled by a distal regulatory element

    bioRxiv : the preprint server for biologyPreprint

More on Apoptosis

USP13

downin mice1

1 study
  1. USP13 is associated with MDM2 in mice.

    “We found a negative correlation between USP13 and MDM2 expression in lung tissues of aged mice.”

    Animalslung

    USP13 regulates cell senescence through mediating MDM2 stability

    Life sciences

More on USP13

Progeria

upin humans1

1 study
  1. MDM2 is linked with a higher risk of progeria in humans (homozygous germline mutation).

    “Altogether, our findings indicate that mutant MDM2 is a likely driver of the observed segmental form of progeria.”

    Humanshomozygous germline mutation

    Dysfunction of the MDM2/p53 axis is linked to premature aging

    The Journal of clinical investigation

More on Progeria

Funding

1 grant since 2020

National Institute on Aging$1.8M

Latest

Dec 2025: 1Jan 2026: 2Feb 2026: 1Mar 2026: 6Apr 2026: 0May 2026: 3Jun 2026: 0Jul 2026: 2Aug 2026: 1Sep 2026: 1Oct 2026: 3Nov 2026: 222 papers in 12 months
bioRxiv

Stress-response protein supports healthy aging in mouse liver

In experiments in aged mice, removing the stress-response protein p53 from liver cells increased inflammation, while activating it with a drug delayed the onset of…In experiments in aged mice, removing the stress-response protein p53 from liver cells increased inflammation, while activating it with a drug delayed the onset of frailty.

Preprint: mouse studyDNA damage response
ACS Nano

Ultrasound-activated scaffold may aid bone repair in rats

Experiments in a rat model supported the bone-regenerating potential of a scaffold that generates electrical stimulation when activated by ultrasound.Experiments in a rat model supported the bone-regenerating potential of a scaffold that generates electrical stimulation when activated by ultrasound.

Cells

Blocking ribosome production caused kidney scarring in mice

In mouse experiments, a drug that blocked production of cells’ protein-making machinery caused kidney scarring before kidney function declined.In mouse experiments, a drug that blocked production of cells’ protein-making machinery caused kidney scarring before kidney function declined.

Mouse studyKidney
Cell Death Discovery

New protein form pushed lab-grown cells to stop dividing

Cell experiments identified a previously unknown protein form that responded to DNA damage and triggered senescence, a state in which cells stop dividing.Cell experiments identified a previously unknown protein form that responded to DNA damage and triggered senescence, a state in which cells stop dividing.

Experiments in cellsMechanisms

See all 121 papers on MDM2